Public procurement and innovation - Bjørn Grønli (Helse Sørøst)Presentation Transcript
Bjørn Grønli Head of InnovationPre-commercial procurementand innovation: Thoughts onhow to approach the challenges
Why innovation?• There is a strong need for a better and more efficient health sector• There is a generally stronger priority of innovation Connecting innovation and procurement can be a smart approach!
Legal framework• General procurement legislation• Art 16 F(exemption) Public authorities can buy innovation without commitment to the procurement directives
PCP Procurement process
The difference between article 16 fand PCP
The tendering process• The EU Commision recommends a strict approach based om equal treatment and transparency• Article 16 f allows a more flexible approach where you can choose a supplier without competition
Basic challenges/risks connectedto PCP approach• No automatic purchase of the developed product/service• The risk of supplier exclusion• The fear of illegal state aid
The typical public procurementofficer• Conservative• Risk reluctant• Bound by budgets• Afraid of doing mistakes – unclear legal frameworkConsequences minimal innovation
Recommendations• The EU Commision promotes strongly innovation and PCP• Several countries have started spesific PCP- programmes (Finland, Denmark, Netherlands, Great Britain among others)• The public buyer needs more support and knowledgde• The potencial must be seen in the light of the gains
What can we gain by integratinginnovation and procurement?• Products bought are not always ”off the shelf”• Within the ICT area there is a rapid innovation development• A large risk of buying yesterdays products and services again and again To modernise the health sector we need to integrate innovation and procurement in a better way!